Synthetic Strategies toward High Entropy Materials: Atoms-to-Lattices for Maximum Disorder
Crystal Growth & Design · 04.10.2023 · 23 (10) · 6998-7009
DOI: 10.1021/acs.cgd.3c00712 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Crystal Growth & Design, online erschienen am 31.08.2023. Verfasst von Mark A Buckingham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Engineering and Physical Sciences Research Council, UK Research and Innovation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Materials, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom.
- Department of Chemistry, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom.
ORCID-Profile: Mark A Buckingham, Jonathan M Skelton, David J Lewis
Förderung
- Medical Research Council
- Engineering and Physical Sciences Research Council
- UK Research and Innovation
- University of Manchester
Zitieren
APA
Buckingham, M. A., Skelton, J. M., & Lewis, D. J. (2023). Synthetic Strategies toward High Entropy Materials: Atoms-to-Lattices for Maximum Disorder. Crystal Growth & Design, 23(10), 6998-7009. https://doi.org/10.1021/acs.cgd.3c00712
Vancouver
Buckingham MA, Skelton JM, Lewis DJ. Synthetic Strategies toward High Entropy Materials: Atoms-to-Lattices for Maximum Disorder. Crystal Growth & Design. 2023;23(10):6998-7009. doi:10.1021/acs.cgd.3c00712
BibTeX
@article{Buckingham2023,
author = {Buckingham, Mark A and Skelton, Jonathan M and Lewis, David J},
title = {Synthetic Strategies toward High Entropy Materials: Atoms-to-Lattices for Maximum Disorder},
journal = {Crystal Growth & Design},
year = {2023},
volume = {23},
number = {10},
pages = {6998--7009},
doi = {10.1021/acs.cgd.3c00712}
}
EUVIMED